{"id":"W3203798531","doi":"10.1177/17588359211039928","title":"ALBI score and outcomes in patients with hepatocellular carcinoma: <i>post hoc</i> analysis of the randomized controlled trial KEYNOTE-240","year":2021,"lang":"en","type":"article","venue":"Therapeutic Advances in Medical Oncology","topic":"Hepatocellular Carcinoma Treatment and Prognosis","field":"Medicine","cited_by":18,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of Toronto","funders":"","keywords":"Medicine; Post-hoc analysis; Internal medicine; Placebo; Pembrolizumab; Hazard ratio; Hepatocellular carcinoma; Confidence interval; Hepatology; Gastroenterology; Liver function; Sorafenib; Cancer; Pathology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001273228,0.000273609,0.003531484,0.0002762017,0.000043321,0.000006111241,0.0001592608,0.0002701604,0.000455199],"category_scores_gemma":[0.0007433671,0.0001396886,0.0005059661,0.0009221406,0.0006993076,0.00006831799,0.00007755653,0.0003995034,0.00000171237],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001285873,"about_ca_system_score_gemma":0.0005917323,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00005512315,"about_ca_topic_score_gemma":0.000416474,"domain_scores_codex":[0.9961596,0.001340637,0.001017825,0.0004014347,0.0007445278,0.0003359478],"domain_scores_gemma":[0.9966027,0.002362366,0.000337316,0.0003698479,0.0001728047,0.000154968],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.412991,0.0009490505,0.5746332,0.00002325977,0.0008855336,0.0001613264,0.0001945212,0.000001704186,0.000004024349,0.00008180254,3.6326e-7,0.01007419],"study_design_scores_gemma":[0.8746054,0.001912853,0.1160181,0.00007376271,0.0040446,0.000006004923,0.00008876459,0.002468779,0.00005774183,0.0001328841,0.0004541795,0.0001368901],"study_design_candidate":"randomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9839346,0.00999792,0.0000697079,0.002015358,0.0001927768,0.003250171,0.000006738707,0.00001100112,0.000521721],"genre_scores_gemma":[0.9970869,0.0009204058,0.0001574974,0.001224983,0.00003288708,0.0003889483,0.0000474991,0.00001810524,0.0001227745],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.4616144,"threshold_uncertainty_score":0.5696336,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01850701140717144,"score_gpt":0.2851676526289131,"score_spread":0.2666606412217417,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}